Q4 2023 |
1 |
$2M |
$0 |
-$86.6K |
-$86.6K |
CBL
|
13F-HR |
2/14/2024, 04:47 PM |
Q3 2023 |
4 |
$1.81M |
+$535K |
-$16.8M |
-$16.3M |
CBL, EBIX, AMPY
|
13F-HR |
11/14/2023, 04:29 PM |
Q2 2023 |
10 |
$18.2M |
+$9.79M |
-$10.5M |
-$761K |
LNTH, CBL, AMPY
|
13F-HR |
8/14/2023, 10:55 AM |
Q1 2023 |
9 |
$18.8M |
+$17.4M |
|
+$17.4M |
LNTH, NVS, UTHR, QQQ, NVO
|
13F-HR |
5/15/2023, 04:24 PM |
Q4 2022 |
7 |
$7.48M |
+$719K |
-$15.2M |
-$14.5M |
LFCR, CBL, LNTH, CORBF, CCEL
|
13F-HR |
2/14/2023, 03:25 PM |
Q3 2022 |
6 |
$58.3M |
+$11.7M |
-$8.04M |
+$3.67M |
NTPIF, LFCR, LNTH, CBL, CCEL
|
13F-HR |
11/14/2022, 03:36 PM |
Q2 2022 |
6 |
$63.6M |
|
|
|
NTPIF, LFCR, MTBL, HMTV, CCEL
|
13F-HR |
8/15/2022, 05:35 PM |
Q1 2022 |
3 |
$52.2M |
|
|
|
NTPIF, CBL, CCEL
|
13F-HR |
5/16/2022, 04:44 PM |
Q4 2021 |
6 |
$152M |
+$43.1M |
-$4.2M |
+$38.9M |
CDMO, NOTV, LFCR, XPEL, CCEL
|
13F-HR |
2/14/2022, 03:32 PM |
Q3 2021 |
7 |
$227M |
+$41.1M |
-$57.2M |
-$16.1M |
NTPIF, CDMO, LFCR, NOTV, XPEL
|
13F-HR |
11/12/2021, 01:52 PM |
Q2 2021 |
8 |
$275M |
+$11.9M |
-$36M |
-$24.1M |
NTPIF, CDMO, DMTK, XPEL, ATEX
|
13F-HR |
8/16/2021, 04:12 PM |
Q1 2021 |
5 |
$212M |
+$88.7M |
-$14.3M |
+$74.4M |
DMTK, NTPIF, CDMO, NOTV, XPEL
|
13F-HR |
5/17/2021, 04:15 PM |
Q4 2020 |
5 |
$86.2M |
+$29.7M |
-$26.4M |
+$3.31M |
CDMO, NTPIF, DMTK, ATEX, XPEL
|
13F-HR |
2/16/2021, 07:50 AM |
Q3 2020 |
5 |
$74.4M |
+$2.08M |
-$4.82M |
-$2.74M |
NTPIF, CDMO, XPEL, WLL, CHS
|
Restatement |
11/16/2020, 04:31 PM |
Q2 2020 |
10 |
$57.2M |
+$449K |
-$28.6M |
-$28.1M |
NTPIF, CDMO, XPEL, KIRK, PEIXXXX
|
13F-HR |
8/14/2020, 09:04 AM |
Q1 2020 |
10 |
$65.2M |
+$19.3M |
|
+$19.3M |
CDMO, NTPIF, XPEL, KIRK, BAC
|
13F-HR |
5/15/2020, 09:55 AM |
Q4 2019 |
3 |
$69.5M |
|
-$19M |
-$19M |
CDMO, NTPIF, XPEL
|
13F-HR |
2/14/2020, 10:56 AM |
Q3 2019 |
4 |
$75.6M |
+$17.2M |
-$1.29M |
+$15.9M |
NTPIF, CDMO, XPEL, TOCA
|
13F-HR |
11/14/2019, 09:08 AM |
Q2 2019 |
2 |
$64M |
+$9.2M |
|
+$9.2M |
NTPIF, CDMO
|
13F-HR |
8/14/2019, 04:14 PM |
Q1 2019 |
5 |
$61.1M |
+$56K |
-$31.5M |
-$31.5M |
NTPIF, CDMO, CDNA, ICON, FRAN
|
13F-HR |
5/15/2019, 10:03 AM |
Q4 2018 |
5 |
$91.5M |
|
|
|
NTPIF, CDNA, CDMO, NIHD, TST
|
13F-HR |
2/14/2019, 11:05 AM |
Q1 2017 |
16 |
$57.5M |
+$43.1M |
-$363K |
+$42.7M |
AMZN, NATH, KEM, TCX, VSAR
|
13F-HR |
5/15/2017, 12:32 PM |
Q4 2016 |
3 |
$15M |
|
-$93.9K |
-$93.9K |
NATH, ALJJ, MMAC
|
13F-HR |
2/14/2017, 10:11 AM |
Q3 2016 |
8 |
$17.7M |
+$4.47M |
|
+$4.47M |
NATH, ALJJ, MMAC, AMZN, CYCC
|
13F-HR |
11/14/2016, 04:00 PM |
Q2 2016 |
3 |
$12.1M |
+$2.79M |
-$1.82M |
+$962K |
NATH, ALJJ, MMAC
|
13F-HR |
8/15/2016, 11:57 AM |
Q1 2016 |
6 |
$17.7M |
+$5.45M |
-$7.98M |
-$2.54M |
NATH, UPIP, MMAC, MNKDXXXX, QLTI
|
13F-HR |
5/16/2016, 02:43 PM |
Q4 2015 |
11 |
$149M |
+$28.7M |
-$30.8M |
-$2.14M |
TARO, UHAL, NATH, CSWI, FUR
|
13F-HR |
2/16/2016, 01:26 PM |
Q3 2015 |
11 |
$176M |
+$18.7M |
-$20.9M |
-$2.24M |
TARO, CSWC, UHAL, FUR, SURG
|
13F-HR |
11/16/2015, 03:06 PM |
Q2 2015 |
8 |
$193M |
+$28.3M |
-$19.3M |
+$9.02M |
TARO, CSWC, UHAL, FUR, ALNY
|
13F-HR |
8/14/2015, 04:13 PM |
Q1 2015 |
9 |
$205M |
+$44.7M |
-$11.9M |
+$32.8M |
TARO, CSWC, TSEM, UHAL, CBM
|
13F-HR |
5/15/2015, 11:40 AM |
Q4 2014 |
12 |
$215M |
+$41.3M |
-$5.5M |
+$35.8M |
TARO, PFF, UHAL, OUTR, FUR
|
13F-HR |
2/17/2015, 07:48 AM |
Q3 2014 |
11 |
$197M |
+$3.49M |
-$2.57M |
+$919K |
TARO, UHAL, NVGS, AMRI, AIQ
|
13F-HR |
11/14/2014, 09:24 AM |
Q2 2014 |
14 |
$193M |
+$8.18M |
-$350K |
+$7.83M |
TARO, UHAL, NVGS, DEPO, AMBCWS
|
13F-HR |
8/14/2014, 12:52 PM |
Q1 2014 |
15 |
$166M |
|
|
|
TARO, UHAL, NVGS, HRTX, DEPO
|
13F-HR |
5/13/2014, 05:59 PM |